News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Penn inventors make the mRNA-based COVID vaccines possible
Drew Weissman, MD, PhD, the Roberts Family Professor of Vaccine Research, and Katalin Karikó, PhD, an adjunct professor of Neurosurgery at Penn, have been awarded multiple prestigious prizes.
Philly just ranked high on a global list of startup ecosystems. These local leaders aren’t surprised
iladelphia landed a spot in the overall top 30 of Startup Genome's Global Startup Ecosystem Report. The city scored highest for its market reach and talent.
Luxturna inventor Jean Bennett starts a new gene therapy company to tackle rare diseases left behind by pharma, VCs
Jean Bennett, who designed and co-developed Luxturna, approved in 2018 for a rare form of blindness, had kept building new gene therapies for eye diseases at her University of Pennsylvania lab.
Katalin Karikó and Drew Weissman named to the 2022 National Inventors Hall of Fame
National Inventors Hall of Fame, in partnership with the United States Patent and Trademark Office, is excited to announce the 2022 Class of Inductees.
Penn engineers will develop on-demand, on-site mRNA manufacturing
With an NSF grant, Penn Engineering researchers are developing a new manufacturing technique that would be able to produce mRNA sequences in a way that removes the need for cryogenic temperatures.
Co-founder of Avisi Technologies named one of the Greater Philadelphia’s Inno Under 25
long with co-founder Brandon Kao, Rui Jing Jiang started Avisi Technologies in 2017, developing VisiPlate, a nanotechnology-enabled ocular implant to treat glaucoma.
At-home COVID-19 results with the click of a smartphone
chers have developed a highly-sensitive rapid antigen test that can detect small loads of SARS-CoV-2
Recupero Robotics launches
Dr. Johnson and a team of collaborators have launched Recupero Robotics with the help of PCI Ventures.
Webinar Recording: Latest Trends in Life Science Investing
PCI hosted a webinar on Septembe 13, 2021 focused on the latest trends in the venture capital landscape. The speaker was Barbara Schilberg, Managing Director and Chief Executive Officer of BioAdvance.
Jean Bennett, M.D., Ph.D., joins REGENXBIO Board of Directors
She will serve as a member of REGENXBIO's Nominating and Corporate Governance Committee.